Personalized Medical Care & Dedicated International Patient Concierge

4.9 Patient Satisfaction

en-US

Medical Clinic LogoMedical ClinicHome
Book Consultation
Book Consultation
Patient Guide
SpecialtiesServicesDoctorsOffersArticlesBefore & AfterReviewsAbout UsContact Us
Stem Cell Therapy Combined with Ozone Therapy: Is a Multi-Modal Protocol Right for You?

Medical Guide

Stem Cell Therapy Combined with Ozone Therapy: Is a Multi-Modal Protocol Right for You?

A careful look at stem cell therapy combined with ozone therapy, including the FDA's position that ozone is a toxic gas with no known useful medical use.

Schedule a Consultation

Medically reviewed by Dr. Seok Lee, Lead Physician, Pentaheal Medical Group

Some regenerative and functional-medicine clinics describe "multi-modal" protocols that pair stem cell or regenerative therapy with additional treatments, and ozone therapy is sometimes among them. If you are considering such a protocol, you deserve a clear, honest, and cautious explanation, not a sales pitch. This article lays out what each component is, what the current US regulatory picture says, and why the ozone component in particular calls for special care. The most important message comes first, because it should shape any decision you make: under US regulation, the FDA holds a firm position that ozone is a toxic gas with no known useful medical application. That single fact deserves serious weight before anyone considers a protocol that includes ozone.

This is not intended to tell you what to do. It is intended to help you understand the landscape and to encourage a frank conversation with a qualified physician about risks before you agree to anything.

The FDA's Position on Ozone

The starting point for any discussion of ozone therapy in a US regulatory context is a specific federal regulation. Under 21 CFR 801.415, the FDA states that ozone is a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy. In the agency's words, in order for ozone to be effective as a germicide, it must be present in a concentration far greater than that which can be safely tolerated by people and animals.

Read that carefully, because the language is unusually direct. The regulation does not merely say ozone therapy is unproven; it characterizes ozone as toxic and states that it has no known useful medical application across specific, adjunctive, or preventive uses. "Adjunctive" is the relevant word for anyone evaluating a multi-modal protocol, because adding ozone as an adjunct to another therapy is exactly the kind of use the regulation addresses. This is the single most important piece of context on this page, and it is why the sections that follow treat any stem-cell-plus-ozone protocol with heightened caution rather than enthusiasm.

Whatever a clinic anywhere in the world may say about ozone therapy, the US regulatory position is unambiguous, and you should factor it into your decision. If any provider proposes ozone therapy to you, it is entirely reasonable to ask them to address this FDA position directly and to explain the specific risks in your case.

What Stem Cell Therapy Is, and Its Regulatory Status

Stem cell and regenerative therapies are studied for their potential to support the body's own repair and tissue-maintenance processes. That phrasing is deliberately exploratory, because the science is still developing and outcomes are not established for most of the conditions people hope to treat.

Crucially, stem cell therapy itself is not approved by the US FDA for safety or effectiveness for degenerative, orthopedic, anti-aging, or systemic conditions. The FDA has warned consumers about unapproved stem cell products, noting that they can carry serious safety risks and that some marketed claims are not supported by evidence. The agency's consumer alert on regenerative medicine products, including stem cells and exosomes, likewise urges people to be cautious, to verify whether a product is FDA-approved or studied under a legitimate pathway, and to understand that "regenerative medicine" marketing does not equal proven benefit.

So even setting ozone aside, the regenerative component of any such protocol is investigational. Combining an investigational therapy with a treatment the FDA regards as a toxic gas with no known useful medical application compounds the uncertainty rather than resolving it. Adding treatments together does not make any of them proven, and it can introduce additional risks.

It is also worth being clear about what "multi-modal" does and does not mean. The term simply signals that more than one therapy is being used together. It is a description of a program's structure, not a measure of its evidence or safety. A protocol with several components is not automatically more thorough, more scientific, or more effective than a single therapy; it may instead mean more variables to evaluate, more potential interactions, and more that must be monitored. When you encounter the phrase, it is reasonable to look past it and ask about each individual component: what it is, what the evidence says, whether it is FDA-approved, and what its specific risks are.

How a Multi-Modal Protocol Is Described, Framed Cautiously

Pentaheal Medical Group is a functional-medicine and longevity-focused clinic in Seocho District, Seoul. Among the services it lists are non-surgical stem cell and regenerative medicine, IV therapy and recovery, and ozone therapy. The clinic describes a diagnostics-first model and states that its regenerative care may be combined with other supportive measures. Presented neutrally, that is the clinic's own model.

The theory behind any multi-modal protocol is that different components address different aspects of a person's health at once. It is essential to treat that as a rationale, not as evidence of benefit. There is no FDA-approved combination therapy of stem cells and ozone, and the FDA's position on ozone specifically weighs against its medical use. A careful reader should not interpret the availability of a service as an endorsement of its safety or effectiveness.

Pentaheal operates under South Korea's advanced regenerative-medicine framework and is registered with the Ministry of Health and Welfare to treat foreign patients. These are Korean regulatory designations, not US FDA approval, and they do not establish proven efficacy. The clinic also does not publicly disclose the source of the cells it uses, so this article cannot characterize them; that is a detail to confirm at consultation. The clinic describes a 1:1 physician care model with Dr. Seok Lee personally involved, and virtual consultations before travel through a dedicated international patient team. You can review how it presents its services on its main website.

None of this alters the core caution. If you are weighing a protocol that includes ozone, the responsible path is to discuss the FDA's position and the specific risks candidly with a qualified physician before proceeding.

For context, the clinic's documented model is diagnostics-first and organized in three broad steps: a functional health evaluation of history, symptoms, and lifestyle; precision diagnostic testing that may examine metabolic and biochemical markers, nutritional and cellular status, hormones, environmental toxins, and inflammatory markers; and then a personalized plan built from those findings. The clinic states that any regenerative care follows from that evaluation and physician judgment rather than being applied automatically, and that its stated philosophy is to treat the root cause, not just the symptoms. Describing this model neutrally does not endorse any particular therapy within it. Even the most thorough evaluation cannot change the fact that ozone is characterized by the FDA as having no known useful medical application, or that stem cell therapy is not FDA-approved for these uses. The evaluation matters because it is the setting in which candidacy, contraindications, risks, and realistic expectations should be examined honestly, one component at a time.

Weighing Risks and Discussing Them With a Physician

The most useful thing you can do is have a direct, informed conversation about risk. A few principles can guide it.

First, treat the regulatory status of each component as real information. Stem cell therapy is not FDA-approved for these uses, and ozone is described by the FDA as a toxic gas with no known useful medical application. That is not a formality to skip past; it is central to informed consent.

Second, remember that combining therapies can multiply, not divide, uncertainty. Each component carries its own considerations, and interactions between them may be poorly understood. More treatment is not automatically better or safer treatment.

Third, insist on individualized evaluation. Whether any therapy is appropriate depends on your specific health status, and there are documented situations where regenerative care is generally not advised, such as active cancer or a cancer history pending evaluation, severe active infection, autoimmune conditions during an acute flare, pregnancy or breastfeeding, severe thrombocytopenia, and other uncontrolled medical conditions. A responsible physician screens for these before recommending anything.

Fourth, be wary of how uncertainty is described to you. If a therapy is framed with exploratory language such as "may support" or "studied for its potential," that wording reflects genuine scientific uncertainty and should not be read as a soft promise of benefit. A responsible conversation names the limits plainly: which components are FDA-approved (none, in the case of a stem-cell-plus-ozone protocol), what the honest evidence shows, and why the FDA characterizes ozone the way it does. No cure or guaranteed outcome should ever be promised, and any figures a clinic states about its own experience are stated facts about that clinic, not evidence that a therapy will work for you.

Fifth, if you are considering traveling abroad for care, plan carefully. The US Centers for Disease Control and Prevention (CDC) advises medical travelers to research the provider and facility, understand the treatment and its risks, arrange for follow-up and possible complications after returning home, and be aware that standards, oversight, and legal recourse can differ from those in the United States. These cautions apply with particular force to unproven or experimental therapies. If you want to ask the clinic questions or arrange a consultation, you can use its contact page. Cost and candidacy are confirmed at consultation, where a deposit is required to confirm a booking and the balance is due before the program begins.

Questions to Bring to a Consultation

  • Given that the FDA characterizes ozone as a toxic gas with no known useful medical application, why is ozone being proposed in my case, and what are the specific risks?
  • Is any component of this protocol FDA-approved for my condition, and if not, what is the honest evidence base?
  • How will you screen me for contraindications, and how are risks monitored during and after treatment?
  • What follow-up is available after I return home, and how would complications be handled?
  • What does the CDC recommend for someone in my situation considering care abroad?

Bottom Line

  • Under US regulation (21 CFR 801.415), the FDA holds that ozone is a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy; this deserves serious weight in any decision.
  • Stem cell therapy is not FDA-approved for safety or effectiveness in the conditions patients typically seek to treat, and the FDA has warned consumers about unapproved regenerative products.
  • Combining an investigational regenerative therapy with ozone does not make either proven and can compound uncertainty and risk.
  • Pentaheal's multi-modal, diagnostics-first model is presented here neutrally as the clinic's own model; availability of a service is not an endorsement of its safety or effectiveness, and Korean regulatory designations are not US FDA approval.
  • Discuss risks candidly with a qualified physician, screen for contraindications, plan follow-up per CDC medical-tourism guidance, and expect no cure or guaranteed outcome; results vary.

Frequently Asked Questions

**What is the FDA's position on ozone therapy?**Under 21 CFR 801.415, the FDA states that ozone is a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy, and that any germicidal effect would require concentrations greater than humans can safely tolerate. This is a direct regulatory position, and it is central to evaluating any protocol that includes ozone.

**Is a stem-cell-plus-ozone protocol FDA-approved?**No. There is no FDA-approved combination therapy of stem cells and ozone. Stem cell therapy is not FDA-approved for the conditions most patients seek to treat, and the FDA regards ozone as a toxic gas with no known useful medical application. Combining them does not create a validated treatment.

**Does combining therapies improve results?**No one can responsibly claim that. The rationale that multiple components address multiple aspects of health is a theory, not proven fact. Combining therapies can add risks and uncertainty rather than benefit, and results vary from person to person.

**Is Pentaheal's use of these therapies an endorsement of their safety?**The availability of a service is not an endorsement of its safety or effectiveness. Pentaheal operates under South Korea's regenerative-medicine framework, which is a Korean designation, not US FDA approval. Any decision should be based on an individual medical evaluation and a candid discussion of risks.

**What should I do if I am considering care abroad?**The CDC advises researching the provider and facility, understanding the treatment and its risks, arranging follow-up and coverage for possible complications, and recognizing that oversight and legal recourse differ by country. Discuss all of this with a qualified physician before making a decision.

**Who should not consider these therapies?**Documented situations where regenerative care is generally not advised include active cancer or a cancer history pending evaluation, severe active infection, autoimmune conditions during an acute flare, pregnancy or breastfeeding, severe thrombocytopenia, and other uncontrolled conditions. A physician should screen for these before recommending anything.

This article is for general informational purposes and does not constitute individualized medical advice. Consult a qualified physician about your specific condition.

More Articles

Continue reading our clinical guides.

View All
Korean Board-Certified Care: Safety in Functional Medicine Standards

Korean Board-Certified Care: Safety in Functional Medicine Standards

Chronic spine, joint, and cancer-related pain affects millions of families across South Korea.

Learn More

Learn More
Functional Medicine Clinic Seoul Korea | PENTAHEAL Guide

Functional Medicine Clinic Seoul Korea | PENTAHEAL Guide

Discover Seoul Korea's top functional medicine clinic for Americans. PENTAHEAL's complete guide to autoimmune, chronic disease and longevity programs in 2026.

Learn More

Learn More
Metabolic Syndrome Treatment Seoul Korea: The PENTAHEAL Protocol

Metabolic Syndrome Treatment Seoul Korea: The PENTAHEAL Protocol

Seeking metabolic syndrome treatment Seoul Korea? PENTAHEAL Medical Group offers a 1:1 metabolic reset program led by Dr. Seok Lee. Book your consult today.

Learn More

Learn More

Medical Clinic

Dedicated to evidence-based medical care, personalized treatment planning, and comprehensive support for local and international patients.

Treatments

SpecialtiesServicesMedical TeamSpecial OffersMedical Articles

Patient Guide

About UsHow It WorksBefore & AfterPatient ReviewsPress & Media

Information & Legal

Contact & LocationSite SearchPrivacy PolicyRefund & Cancellation PolicyTerms of Use

© Medical Clinic. All rights reserved.

Individual clinical results may vary. Please consult a board-certified specialist.